scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/S00296-003-0289-0 |
P698 | PubMed publication ID | 12634936 |
P2093 | author name string | Ismail Celik | |
Sedat Kiraz | |||
Meral Calgüneri | |||
Ihsan Ertenli | |||
M Akif Oztürk | |||
Ibrahim c Haznedaroğlu | |||
P2860 | cites work | Plasma interleukin-6 and C-reactive protein levels in reactive versus clonal thrombocytosis | Q72761104 |
Establishment of nurse-like stromal cells from bone marrow of patients with rheumatoid arthritis: indication of characteristic bone marrow microenvironment in patients with rheumatoid arthritis | Q73069503 | ||
Circulating levels of thrombopoietic and inflammatory cytokines in patients with clonal and reactive thrombocytosis | Q73082497 | ||
Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant | Q73231301 | ||
Detection and quantitation of stem cell factor (kit ligand) in the synovial fluid of patients with rheumatic disease | Q73324331 | ||
High serum and synovial fluid granulocyte colony stimulating factor (G-CSF) concentrations in patients with rheumatoid arthritis | Q73345428 | ||
The synovial expression and serum levels of interleukin-6, interleukin-11, leukemia inhibitory factor, and oncostatin M in rheumatoid arthritis | Q73414195 | ||
Rheumatoid synovial fluid contains bioactive leukemia inhibitory factor with cartilage degrading activity--another target for chondroprotective intervention | Q73471417 | ||
Reactive and clonal thrombocytosis: proinflammatory and hematopoietic cytokines and acute phase proteins | Q73828041 | ||
Thrombopoietin levels in patients with primary and reactive thrombocytosis | Q73892955 | ||
Connective tissue activation. XXXVII. Effects of cytokine combinations, implications for an integrated cytokine network | Q73893252 | ||
Induction of c-kit molecules on human CD34+/c-kit < low cells: evidence for CD34+/c-kit < low cells as primitive hematopoietic stem cells | Q73949310 | ||
Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis? | Q74006114 | ||
Interleukin-4 inhibits interleukin-11 production by rheumatoid synovial cells | Q74046787 | ||
Quantitation of the activity of rheumatoid arthritis. 5. A method for summation of the systemic indices of rheumatoid activity | Q74235228 | ||
Circulating thrombopoietin in clonal versus reactive thrombocytosis | Q74597209 | ||
Thrombopoietin | Q77218573 | ||
Interleukin-1alpha and tumor necrosis factor alpha synergistically stimulate prostaglandin E2-dependent production of interleukin-11 in rheumatoid synovial fibroblasts | Q77539476 | ||
Elevated serum thrombopoietin and interleukin-6 concentrations in thrombocytosis associated with inflammatory bowel disease | Q78148964 | ||
Transforming growth factor-beta1 (TGF-beta1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-beta receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-beta itself with | Q78225305 | ||
Bloodstream thrombopoietin in rheumatoid arthritis with thrombocytosis | Q78560054 | ||
Structure of the human gene encoding granule membrane protein-140, a member of the selectin family of adhesion receptors for leukocytes | Q24305323 | ||
Structural and biological characteristics of connective tissue activating peptide (CTAP-III), a major human platelet-derived growth factor | Q24601871 | ||
Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human interleukin-11 (rhIL-11) in the treatment of subjects with active rheumatoid arthritis | Q24800647 | ||
Cytokine signal transduction | Q28258951 | ||
Hepatic thrombopoietin mRNA is increased in acute inflammation | Q28575389 | ||
Hematopoietic growth factors: overview and clinical applications, Part I. | Q30455192 | ||
Characterization of GMP-140 (P-selectin) as a circulating plasma protein | Q30988941 | ||
Hematopoietic, immunomodulatory and epithelial effects of interleukin-11. | Q33329998 | ||
Cytokines, endothelium, and adhesive molecules in pathologic thrombopoiesis | Q33336747 | ||
Interleukin-11. | Q33377512 | ||
Murine thrombopoietin mRNA levels are modulated by platelet count | Q33488542 | ||
The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit | Q33489633 | ||
Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization | Q33498092 | ||
Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura, aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells | Q33502872 | ||
Thrombopoietin and its receptor: structure, function and role in the regulation of platelet production | Q33546326 | ||
Thrombocytosis of active rheumatoid disease | Q33554737 | ||
Human epidermal growth factor for the stratification of synovial lining layer and neovascularisation in rheumatoid arthritis | Q33562073 | ||
Anti-interleukin 6 receptor antibody treatment in rheumatic disease | Q34071253 | ||
Association between a single-nucleotide polymorphism in the promoter of the human interleukin-3 gene and rheumatoid arthritis in Japanese patients, and maximum-likelihood estimation of combinatorial effect that two genetic loci have on susceptibilit | Q34113270 | ||
Interleukin-11: a new cytokine critical for osteoclast development | Q34138407 | ||
Synergistic activity of interleukin-4 and interleukin-10 in suppression of inflammation and joint destruction in rheumatoid arthritis | Q34158420 | ||
Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro | Q34294815 | ||
Expression and secretion of type beta transforming growth factor by activated human macrophages | Q34341606 | ||
Interleukin 4 (B-cell stimulatory factor 1) can enhance or antagonize the factor-dependent growth of hemopoietic progenitor cells | Q34350582 | ||
Pluripotent hemopoietic stem cells are c-kitQ34423590 | | ||
Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development | Q34425414 | ||
Effects of B cell stimulatory factor-1/interleukin 4 on hematopoietic progenitor cells | Q68822448 | ||
Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with monoclonal antibodies | Q68938647 | ||
Mast cell numbers in rheumatoid synovial tissues. Correlations with quantitative measures of lymphocytic infiltration and modulation by antiinflammatory therapy | Q68942078 | ||
Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor | Q69083448 | ||
Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis | Q69532920 | ||
Interleukin-6 is a potent thrombopoietic factor in vivo in mice | Q69743063 | ||
In vivo platelet survival in rheumatoid arthritis | Q70458584 | ||
Interleukin 10 cooperates with interleukin 4 to suppress inflammatory cytokine production by freshly prepared adherent rheumatoid synovial cells | Q70988634 | ||
Thrombopoietin, megakaryocytopoietic cytokines, and reactive versus clonal megakaryocytopoiesis: an enigma complex | Q71017625 | ||
Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia | Q71096713 | ||
Effects of desmopressin on circulating P-selectin | Q71099056 | ||
Platelets in the synovial fluid of patients with rheumatoid arthritis | Q71339988 | ||
Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis | Q71475041 | ||
Remarkable elevation of interleukin 6 and interleukin 8 levels in the bone marrow serum of patients with rheumatoid arthritis | Q71641544 | ||
Thrombopoietin (c-mpl ligand) acts synergistically with erythropoietin, stem cell factor, and interleukin-11 to enhance murine megakaryocyte colony growth and increases megakaryocyte ploidy in vitro | Q71685959 | ||
Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activity | Q71701983 | ||
Expression of basic fibroblast growth factor in synovial tissue from patients with rheumatoid arthritis and degenerative joint disease | Q71755079 | ||
Effects of lnterleukin-1 and Tumor Necrosis Factor on Megakaryocytopoiesis: Mechanism of Reactive Thrombocytosis | Q71968982 | ||
Human interleukin-4 inhibits proliferation of megakaryocyte progenitor cells in culture | Q72068985 | ||
Interleukin-4 but not interleukin-10 inhibits the production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes | Q72370429 | ||
Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients | Q35550183 | ||
Leukemia inhibitory factor levels are elevated in septic shock and various inflammatory body fluids | Q35609090 | ||
Monocyte-endothelial adhesion in chronic rheumatoid arthritis. In situ detection of selectin and integrin-dependent interactions | Q35610854 | ||
Regulation of arachidonic acid, eicosanoid, and phospholipase A2 levels in murine mast cells by recombinant stem cell factor | Q35763079 | ||
Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization | Q36018621 | ||
Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth | Q36351780 | ||
Coexpression of GMP-140 and PAF by endothelium stimulated by histamine or thrombin: a juxtacrine system for adhesion and activation of neutrophils | Q36532906 | ||
Investigation of blood platelets in synovial fluid from patients with rheumatoid arthritis | Q36642920 | ||
Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption | Q37394770 | ||
Platelet-derived growth factor--a growth factor with an expanding role in health and disease | Q37875458 | ||
Transforming growth factor-beta in rheumatoid arthritis | Q37886463 | ||
Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis | Q37908865 | ||
Osteoblasts and stromal cells isolated from femora in rheumatoid arthritis (RA) and osteoarthritis (OA) patients express IL-11, leukaemia inhibitory factor and oncostatin M. | Q38316574 | ||
The interleukins | Q38696486 | ||
Synovial cells from a patient with rheumatoid arthritis produce osteoclastogenesis inhibitory factor/osteoprotegerin: reciprocal regulation of the production by inflammatory cytokines and basic fibroblast growth factor | Q39122217 | ||
The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. | Q40486326 | ||
Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis | Q40565765 | ||
Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis | Q40772902 | ||
Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis | Q40904867 | ||
Synoviocytes synthesize, bind, and respond to basic fibroblast growth factor | Q41199586 | ||
Thrombocytosis after major lower extremity trauma: mechanism and possible role in free flap failure. | Q41200987 | ||
Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF) | Q41627045 | ||
Stem cell factor induces mast cell adhesion to fibronectin. | Q41660106 | ||
Elevated serum interleukin-6 levels in patients with reactive thrombocytosis | Q41661681 | ||
Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis | Q41666122 | ||
Interleukin 4 induces selective production of interleukin 6 from normal human B lymphocytes | Q41967294 | ||
Increased levels of leukemia inhibitory factor in synovial fluid from patients with rheumatoid arthritis and other inflammatory arthritides | Q44423590 | ||
Interleukin 4 induces interleukin 6 production by endothelial cells: synergy with interferon-gamma | Q44445115 | ||
Platelet-derived growth factor and IL-1 interactions in rheumatoid arthritis. Regulation of synoviocyte proliferation, prostaglandin production, and collagenase transcription | Q44671490 | ||
Connective tissue activation. XXXV. Detection of connective tissue activating peptide-III isoforms in synovium from osteoarthritis and rheumatoid arthritis patients: patterns of interaction with other synovial cytokines in cell culture | Q44896680 | ||
The role of interleukin 6 and interleukin 1 in megakaryocyte development. | Q45940834 | ||
Regulation of synovial cell growth. Coexpression of transforming growth factor beta and basic fibroblast growth factor by cultured synovial cells | Q46877620 | ||
Important immunoregulatory role of interleukin-11 in the inflammatory process in rheumatoid arthritis | Q47685842 | ||
P-selectin as a circulating molecular marker in rheumatoid arthritis with thrombocytosis. | Q47957363 | ||
Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis | Q47977051 | ||
Soluble P-selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. | Q50943889 | ||
von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis. | Q51038872 | ||
Megakaryocytopoiesis: the state of the art. | Q52207242 | ||
IL-3 induces differentiation of bone marrow precursor cells to osteoclast-like cells. | Q52266894 | ||
Growth factors affecting human thrombocytopoiesis: potential agents for the treatment of thrombocytopenia | Q55041393 | ||
Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases | Q57859142 | ||
Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony-stimulating factor | Q58411945 | ||
Connective tissue activation. XII. Platelet abnormalities in patients with rheumatoid arthritis | Q67356822 | ||
GMP-140 (P-selectin/CD62) binds to chronically stimulated but not resting CD4+ T lymphocytes and regulates their production of proinflammatory cytokines | Q67539003 | ||
Cytokine regulation of colony-stimulating factor production in cultured human synovial fibroblasts: I. Induction of GM-CSF and G-CSF production by interleukin-1 and tumor necrosis factor | Q67675729 | ||
Human articular cartilage and chondrocytes produce hemopoietic colony-stimulating factors in culture in response to IL-1 | Q67697147 | ||
Effects of the stem cell factor, c-kit ligand, on human megakaryocytic cells | Q67894798 | ||
Characterization of platelet-derived growth factor beta-receptor expressing cells in the vasculature of human rheumatoid synovium | Q67914082 | ||
Interleukin-6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides | Q68094829 | ||
Relatonship between interleukin–6 levels and platelet counts in systemic juvenile rheumatoid arthritis: comment on the article by De benedetti et al | Q68191450 | ||
P433 | issue | 2 | |
P921 | main subject | rheumatoid arthritis | Q187255 |
P304 | page(s) | 49-60 | |
P577 | publication date | 2003-02-11 | |
P1433 | published in | Rheumatology International | Q15763689 |
P1476 | title | Pathologic thrombopoiesis of rheumatoid arthritis | |
P478 | volume | 23 |
Q37663613 | A Study on Association between Common Haematological Parameters and Disease Activity in Rheumatoid Arthritis |
Q24303899 | Assessment of some tools for the characterization of the human osteoarthritic cartilage proteome |
Q37182199 | Changes of Platelet Indices in Juvenile Idiopathic Arthritis in Acute Phase and After Two Months Treatment |
Q43213477 | Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia |
Q33548150 | Differing effect of systemic anti psoriasis therapies on platelet physiology--a case report and review of literature |
Q37333790 | Early growth response-1 (EGR-1) and nuclear factor of activated T cells (NFAT) cooperate to mediate CD40L expression in megakaryocytes and platelets |
Q35867724 | Levels of thrombopoietin in aqueous humor of patients with noninfectious acute anterior uveitis |
Q50246344 | Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds |
Q37730557 | Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications. |
Q46785420 | Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis |
Q33378654 | Soluble platelet glycoprotein V in distinct disease states of pathological thrombopoiesis. |
Q84969422 | The relationship between mean platelet volume levels and the inflammation in Helicobacter pylori gastritis |
Q38190956 | Thrombocytosis as a prognostic marker in gastrointestinal cancers |
Q83226605 | Thrombocytosis in rheumatoid arthritis: JAK2V617F-positive essential thrombocythemia |
Q35433259 | Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies |
Search more.